Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App





HORIBA Exhibits Compact Benchtop Hematology Analyzers

By LabMedica International staff writers
Posted on 03 Feb 2025

HORIBA (Kyoto, Japan) is presenting its latest IVD solutions at Medlab Middle East 2025, including the

labmedica.com/expo/product/4456/automated-hematology-analyzer-model-yumizen-h550" target="_blank">Yumizen H550 and H500 hematology analyzers.

The HORIBA Medical Segment designs, develops, and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics, and university hospitals. HORIBA’s expertise in vitro diagnostics is one of the most respected in hematology worldwide. The new generation of HORIBA’s automated hematology analyzer offers solid and reliable diagnostic technology as well as rapid and consistent results. HORIBA provides a wide range of hematology analyzers and automated instruments to realize blood analysis (blood cell identification and counting) for the diagnosis of various blood-related diseases. These instruments are designed for all kinds of laboratories, from small laboratories (to 150 patients a day), to larger ones (more than 2000 patients a day). These efficient and reliable instruments feature automated racks, data management, and quality tools providing a complete solution for meeting high-quality medical analysis requirements.

The new Yumizen H500 and H550 compact benchtop hematology analyzers featured at Medlab Middle East 2025 deliver enhanced performance, new features, and increased benefits. Both analyzers come with optional infectious flags for malaria and dengue, making them ideal for small labs to meet a variety of clinical lab environments and settings such as routine hematology, satellite labs, oncology care, and blood banks. HORIBA is also highlighting HELO 2.0, an innovative solution covering all the needs of a high throughput automated hematology platform. Flexible and efficient, HELO 2.0 is the optimum answer to the constant evolution of laboratories. Thanks to its data, tube management, waste, blood film, and digitalization management capability, HELO 2.0 not only fulfills all the needs of laboratories but also helps optimize their TAT, floor space, and reagent storage.


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Gold Member
Hybrid Pipette
SWITCH
New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.